Feldman J M, Blalock J A, Fagraeus L, Miller J N, Farrell R E, Wells S A
Ann Surg. 1978 Dec;188(6):758-68. doi: 10.1097/00000658-197812000-00008.
Using a sensitive and specific radioenzymatic assay, the plasma norepinephrine (NE) concentration was measured in seven patients with pheochromocytoma, one patient with bilateral adrenal medullary hyperplasia, one patient with a retroperitoneal paraganglioma, and two patients undergoing bilateral adrenalectomies for palliation of metastatic breast carcinoma. Surgical manipulation of the pheochromocytomas resulted in striking increases in plasma NE concentration with concomitant increases in blood pressure. There were either small changes or no changes in the patients' plasma NE and blood pressure during resection of the normal adrenal glands, the adrenal glands with medullary hyperplasia, or the retroperitoneal paraganglioma. Plasma dopamine-beta-hydroxylase (DBH) was measured in one patient with pheochromocytomas and the patient with medullary hyperplasia. There was no change in plasma DBH in either patient, supporting the concept that exocytosis is not the primary mechanism for catecholamine secretion from pheochromocytomas. It was also noted that enflurane is an excellent general anesthetic for the resection of pheochromocytomas, and that sodium nitroprusside (rather than phentolamine) may be the agent of choice for the management of the hypertensive episodes that occur during surgical manipulation of pheochromocytomas.
采用灵敏且特异的放射酶分析法,对7例嗜铬细胞瘤患者、1例双侧肾上腺髓质增生患者、1例腹膜后副神经节瘤患者以及2例因转移性乳腺癌行双侧肾上腺切除术以缓解症状的患者的血浆去甲肾上腺素(NE)浓度进行了测定。对嗜铬细胞瘤进行手术操作导致血浆NE浓度显著升高,同时血压也随之升高。在切除正常肾上腺、肾上腺髓质增生的肾上腺或腹膜后副神经节瘤的过程中,患者的血浆NE和血压要么变化很小,要么没有变化。对1例嗜铬细胞瘤患者和1例肾上腺髓质增生患者测定了血浆多巴胺-β-羟化酶(DBH)。两位患者的血浆DBH均无变化,这支持了胞吐作用并非嗜铬细胞瘤分泌儿茶酚胺的主要机制这一观点。还注意到,恩氟烷是切除嗜铬细胞瘤的一种优良全身麻醉药,并且硝普钠(而非酚妥拉明)可能是处理嗜铬细胞瘤手术操作过程中发生的高血压发作的首选药物。